MGTX as of Oct 31 · 12:17 ET
MGTXNasdaqBiological Products, (No Diagnostic Substances)
MeiraGTx Holdings plc · Brief
Next report
12 days
Nov 12 · before openest.Q3 FY26
Expected move
Inputs0 of 8≥ implied
- avg implied
- ±35.8%
- avg realized
- ±6.4%
Nov 13 '24±32.8%▲+5.71%×0.17
Mar 13 '25±59.7%▲+28.71%×0.48
May 13 '25±15.0%▼−8.36%×0.56
Aug 14 '25±34.5%▼−0.12%×0.00
Q3 FY25±39.0%▼−4.62%×0.12
Q1 FY26±48.4%▼−1.18%×0.02
May 14 '26±23.0%▼−0.20%×0.01
Q2 FY26±34.0%▼−2.24%×0.07
quarterimplied−60%0+60%realized×
Q2 FY26±34.0%▼−2.24%×0.07
May '26±23.0%▼−0.20%×0.01
Q1 FY26±48.4%▼−1.18%×0.02
Q3 FY25±39.0%▼−4.62%×0.12
Aug '25±34.5%▼−0.12%×0.00
May '25±15.0%▼−8.36%×0.56
2 older reports
Mar '25±59.7%▲+28.71%×0.48
Nov '24±32.8%▲+5.71%×0.17
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 12 report · est.Bull2 of 3
Bear2
AI captions · Sep 16 '26once per report · top 2 per case
Linked exposure
MGTX report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.